$JAZZ Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Jazz Pharmaceuticals plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Jazz Pharmaceuticals plc. Get notifications about new insider transactions in Jazz Pharmaceuticals plc for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 14 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | A | 175.19 | 570 | 99,858 | 570 | |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 170.09 | 437 | 74,329 | 29,590 | 30 K to 29.6 K (-1.46 %) |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Grant | A | 0.00 | 7,675 | 0 | 30,027 | 22.4 K to 30 K (+34.34 %) |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 175.19 | 6,435 | 1,127,348 | 6,435 | |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 175.19 | 565 | 98,982 | 565 | |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 170.09 | 373 | 63,444 | 23,644 | 24 K to 23.6 K (-1.55 %) |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Grant | A | 0.00 | 2,685 | 0 | 24,017 | 21.3 K to 24 K (+12.59 %) |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Option Exercise | A | 175.19 | 7,000 | 1,226,330 | 7,000 | |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Grant | A | 0.00 | 2,685 | 0 | 12,685 | 10 K to 12.7 K (+26.85 %) |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, R&D & CMO | Option Exercise | A | 175.19 | 14,430 | 2,527,992 | 14,430 | |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, R&D & CMO | Option Exercise | A | 175.19 | 570 | 99,858 | 570 | |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, R&D & CMO | Payment of Exercise | F | 170.09 | 704 | 119,743 | 40,114 | 40.8 K to 40.1 K (-1.72 %) |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, R&D & CMO | Grant | A | 0.00 | 5,755 | 0 | 40,818 | 35.1 K to 40.8 K (+16.41 %) |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | Head of EUSA Int'l ... | Option Exercise | A | 175.19 | 7,500 | 1,313,925 | 7,500 | |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | Head of EUSA Int'l ... | Payment of Exercise | F | 170.09 | 785 | 133,521 | 25,514 | 26.3 K to 25.5 K (-2.98 %) |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | Head of EUSA Int'l ... | Grant | A | 0.00 | 2,875 | 0 | 26,299 | 23.4 K to 26.3 K (+12.27 %) |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Option Exercise | A | 175.19 | 11,979 | 2,098,601 | 11,979 | |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Option Exercise | A | 175.19 | 521 | 91,274 | 521 | |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Grant | A | 0.00 | 4,795 | 0 | 14,860 | 10.1 K to 14.9 K (+47.64 %) |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Option Exercise | A | 175.19 | 19,430 | 3,403,942 | 19,430 | |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Option Exercise | A | 175.19 | 570 | 99,858 | 570 | |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Payment of Exercise | F | 170.09 | 939 | 159,715 | 54,311 | 55.3 K to 54.3 K (-1.70 %) |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Grant | A | 0.00 | 7,675 | 0 | 55,250 | 47.6 K to 55.3 K (+16.13 %) |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Option Exercise | A | 175.19 | 71,930 | 12,601,417 | 71,930 | |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Option Exercise | A | 175.19 | 570 | 99,858 | 570 | |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Payment of Exercise | F | 170.09 | 3,442 | 585,450 | 573,489 | 576.9 K to 573.5 K (-0.60 %) |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Grant | A | 0.00 | 27,800 | 0 | 576,931 | 549.1 K to 576.9 K (+5.06 %) |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Option Exercise | A | 175.19 | 19,430 | 3,403,942 | 19,430 | |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Option Exercise | A | 175.19 | 570 | 99,858 | 570 | |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 170.09 | 948 | 161,245 | 67,124 | 68.1 K to 67.1 K (-1.39 %) |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Grant | A | 0.00 | 7,675 | 0 | 68,072 | 60.4 K to 68.1 K (+12.71 %) |
Feb 12 2015 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, R&D & CMO | Option Exercise | M | 46.83 | 5,000 | 234,150 | 25,019 | |
Feb 12 2015 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, R&D & CMO | Sell | S | 167.34 | 2,000 | 334,672 | 35,063 | 37.1 K to 35.1 K (-5.40 %) |
Feb 12 2015 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, R&D & CMO | Sell | S | 166.48 | 3,000 | 499,446 | 37,063 | 40.1 K to 37.1 K (-7.49 %) |
Feb 12 2015 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, R&D & CMO | Buy | M | 46.83 | 5,000 | 234,150 | 40,063 | 35.1 K to 40.1 K (+14.26 %) |
Feb 12 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Option Exercise | M | 46.83 | 1,851 | 86,682 | 50,556 | |
Feb 12 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Sell | S | 166.90 | 1,851 | 308,932 | 47,575 | 49.4 K to 47.6 K (-3.74 %) |
Feb 12 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Buy | M | 46.83 | 1,851 | 86,682 | 49,426 | 47.6 K to 49.4 K (+3.89 %) |
Feb 12 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 166.90 | 5,000 | 834,500 | 549,131 | 554.1 K to 549.1 K (-0.90 %) |
Feb 12 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 168.13 | 3 | 504 | 6,679 | 6.7 K to 6.7 K (-0.04 %) |
Feb 12 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 167.51 | 68 | 11,391 | 6,682 | 6.8 K to 6.7 K (-1.01 %) |
Feb 12 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 166.45 | 125 | 20,807 | 6,750 | 6.9 K to 6.8 K (-1.82 %) |
Feb 12 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 168.14 | 197 | 33,123 | 333,321 | 333.5 K to 333.3 K (-0.06 %) |
Feb 12 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 167.51 | 3,382 | 566,507 | 333,518 | 336.9 K to 333.5 K (-1.00 %) |
Feb 12 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 166.46 | 6,225 | 1,036,187 | 336,900 | 343.1 K to 336.9 K (-1.81 %) |
Jan 15 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Option Exercise | M | 46.83 | 1,851 | 86,682 | 52,407 | |
Jan 15 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Sell | S | 161.73 | 1,851 | 299,362 | 47,575 | 49.4 K to 47.6 K (-3.74 %) |
Jan 15 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Buy | M | 46.83 | 1,851 | 86,682 | 49,426 | 47.6 K to 49.4 K (+3.89 %) |
Jan 15 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Gift | G | 0.00 | 220 | 0 | 47,575 | 47.8 K to 47.6 K (-0.46 %) |
Jan 15 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Sell | S | 161.73 | 5,000 | 808,650 | 554,131 | 559.1 K to 554.1 K (-0.89 %) |
Jan 07 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 161.54 | 9 | 1,454 | 6,875 | 6.9 K to 6.9 K (-0.13 %) |
Jan 07 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 160.75 | 88 | 14,146 | 6,884 | 7 K to 6.9 K (-1.26 %) |
Jan 07 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 159.68 | 100 | 15,968 | 6,972 | 7.1 K to 7 K (-1.41 %) |
Jan 07 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 161.57 | 495 | 79,975 | 343,125 | 343.6 K to 343.1 K (-0.14 %) |
Jan 07 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 160.75 | 4,348 | 698,938 | 343,620 | 348 K to 343.6 K (-1.25 %) |
Jan 07 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 159.68 | 4,960 | 792,002 | 347,968 | 352.9 K to 348 K (-1.41 %) |
Dec 29 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 167.25 | 100 | 16,725 | 1,257,205 | 1.3 M to 1.3 M (-0.01 %) |
Dec 29 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 166.43 | 2,408 | 400,768 | 1,257,305 | 1.3 M to 1.3 M (-0.19 %) |
Dec 29 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 165.34 | 800 | 132,268 | 1,259,713 | 1.3 M to 1.3 M (-0.06 %) |
Dec 29 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 167.33 | 78 | 13,052 | 1,260,513 | 1.3 M to 1.3 M (-0.01 %) |
Dec 29 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 166.54 | 5,086 | 847,011 | 1,260,591 | 1.3 M to 1.3 M (-0.40 %) |
Dec 29 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 165.67 | 4,832 | 800,531 | 1,265,677 | 1.3 M to 1.3 M (-0.38 %) |
Dec 29 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 164.69 | 2,499 | 411,552 | 1,270,509 | 1.3 M to 1.3 M (-0.20 %) |
Dec 29 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 163.47 | 422 | 68,985 | 1,273,008 | 1.3 M to 1.3 M (-0.03 %) |
Dec 29 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 162.21 | 500 | 81,103 | 1,273,430 | 1.3 M to 1.3 M (-0.04 %) |
Dec 29 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 165.86 | 150 | 24,879 | 1,273,930 | 1.3 M to 1.3 M (-0.01 %) |
Dec 29 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 165.22 | 1,600 | 264,355 | 1,274,080 | 1.3 M to 1.3 M (-0.13 %) |
Dec 29 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 163.55 | 5,118 | 837,043 | 1,275,680 | 1.3 M to 1.3 M (-0.40 %) |
Dec 29 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 162.59 | 9,394 | 1,527,320 | 1,280,798 | 1.3 M to 1.3 M (-0.73 %) |
Dec 29 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 161.77 | 10,343 | 1,673,191 | 1,290,192 | 1.3 M to 1.3 M (-0.80 %) |
Dec 29 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 160.59 | 6,670 | 1,071,108 | 1,300,535 | 1.3 M to 1.3 M (-0.51 %) |
Dec 16 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 172.53 | 300 | 51,759 | 1,650 | 2 K to 1.7 K (-15.38 %) |
Dec 16 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 171.68 | 650 | 111,588 | 1,950 | 2.6 K to 2 K (-25.00 %) |
Dec 16 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 170.32 | 1,393 | 237,256 | 2,600 | 4 K to 2.6 K (-34.89 %) |
Dec 11 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Option Exercise | M | 46.83 | 1,347 | 63,080 | 54,258 | |
Dec 11 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Sell | S | 178.79 | 1,852 | 331,119 | 47,795 | 49.6 K to 47.8 K (-3.73 %) |
Dec 11 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Buy | M | 46.83 | 1,347 | 63,080 | 49,647 | 48.3 K to 49.6 K (+2.79 %) |
Dec 11 2014 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Sell | S | 178.79 | 5,000 | 893,950 | 559,131 | 564.1 K to 559.1 K (-0.89 %) |
Dec 03 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 177.10 | 5 | 886 | 7,072 | 7.1 K to 7.1 K (-0.07 %) |
Dec 03 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 174.97 | 10 | 1,750 | 7,077 | 7.1 K to 7.1 K (-0.14 %) |
Dec 03 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 173.73 | 48 | 8,339 | 7,087 | 7.1 K to 7.1 K (-0.67 %) |
Dec 03 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 173.03 | 60 | 10,382 | 7,135 | 7.2 K to 7.1 K (-0.83 %) |
Dec 03 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 171.65 | 25 | 4,291 | 7,195 | 7.2 K to 7.2 K (-0.35 %) |
Dec 03 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 170.96 | 48 | 8,206 | 7,220 | 7.3 K to 7.2 K (-0.66 %) |
Dec 03 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 177.10 | 295 | 52,245 | 352,928 | 353.2 K to 352.9 K (-0.08 %) |
Dec 03 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 174.97 | 490 | 85,735 | 353,223 | 353.7 K to 353.2 K (-0.14 %) |
Dec 03 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 173.73 | 2,403 | 417,466 | 353,713 | 356.1 K to 353.7 K (-0.67 %) |
Dec 03 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 173.02 | 3,007 | 520,280 | 356,116 | 359.1 K to 356.1 K (-0.84 %) |
Dec 03 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 171.65 | 1,208 | 207,349 | 359,123 | 360.3 K to 359.1 K (-0.34 %) |
Dec 03 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 170.97 | 2,401 | 410,495 | 360,331 | 362.7 K to 360.3 K (-0.66 %) |
Nov 25 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 170.12 | 4,598 | 782,231 | 34,940 | 39.5 K to 34.9 K (-11.63 %) |
Nov 18 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 173.32 | 1,000 | 173,320 | 39,538 | 40.5 K to 39.5 K (-2.47 %) |
Nov 13 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Option Exercise | M | 46.83 | 667 | 31,236 | 55,605 | |
Nov 13 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Sell | S | 173.63 | 1,852 | 321,563 | 48,249 | 50.1 K to 48.2 K (-3.70 %) |
Nov 13 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Buy | M | 46.83 | 667 | 31,236 | 50,101 | 49.4 K to 50.1 K (+1.35 %) |
Nov 13 2014 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Sell | S | 173.63 | 5,000 | 868,150 | 564,023 | 569 K to 564 K (-0.88 %) |
Nov 12 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 171.71 | 46 | 7,899 | 7,268 | 7.3 K to 7.3 K (-0.63 %) |
Nov 12 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 170.90 | 151 | 25,805 | 7,314 | 7.5 K to 7.3 K (-2.02 %) |
Nov 12 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 171.71 | 2,258 | 387,716 | 362,732 | 365 K to 362.7 K (-0.62 %) |
Nov 12 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 170.90 | 7,545 | 1,289,438 | 364,990 | 372.5 K to 365 K (-2.03 %) |
Nov 10 2014 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | Head of EUSA Int'l ... | Option Exercise | M | 59.13 | 1,500 | 88,695 | 7,000 | |
Nov 10 2014 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | Head of EUSA Int'l ... | Option Exercise | M | 46.83 | 4,166 | 195,094 | 18,334 | |
Nov 10 2014 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | Head of EUSA Int'l ... | Sell | S | 172.00 | 1,400 | 240,800 | 23,424 | 24.8 K to 23.4 K (-5.64 %) |
Nov 10 2014 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | Head of EUSA Int'l ... | Sell | S | 172.03 | 5,666 | 974,730 | 24,824 | 30.5 K to 24.8 K (-18.58 %) |
Nov 10 2014 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | Head of EUSA Int'l ... | Buy | M | 59.13 | 1,500 | 88,695 | 30,490 | 29 K to 30.5 K (+5.17 %) |
Nov 10 2014 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | Head of EUSA Int'l ... | Buy | M | 46.83 | 4,166 | 195,094 | 28,990 | 24.8 K to 29 K (+16.78 %) |
Nov 10 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 59.13 | 2,000 | 118,260 | 6,250 | |
Nov 10 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 46.83 | 5,000 | 234,150 | 10,702 | |
Nov 10 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 170.00 | 596 | 101,320 | 21,117 | 21.7 K to 21.1 K (-2.74 %) |
Nov 10 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 170.12 | 7,000 | 1,190,837 | 21,713 | 28.7 K to 21.7 K (-24.38 %) |
Nov 10 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 59.13 | 2,000 | 118,260 | 28,713 | 26.7 K to 28.7 K (+7.49 %) |
Nov 10 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 46.83 | 5,000 | 234,150 | 26,713 | 21.7 K to 26.7 K (+23.03 %) |
Oct 16 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Option Exercise | M | 46.83 | 667 | 31,236 | 56,272 | |
Oct 16 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Sell | S | 150.00 | 667 | 100,050 | 49,434 | 50.1 K to 49.4 K (-1.33 %) |
Oct 16 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Buy | M | 46.83 | 667 | 31,236 | 50,101 | 49.4 K to 50.1 K (+1.35 %) |
Oct 16 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Sell | S | 142.77 | 1,185 | 169,182 | 49,434 | 50.6 K to 49.4 K (-2.34 %) |
Oct 14 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 154.04 | 1,000 | 154,040 | 40,538 | 41.5 K to 40.5 K (-2.41 %) |
Oct 16 2014 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Sell | S | 142.77 | 5,000 | 713,850 | 569,023 | 574 K to 569 K (-0.87 %) |
Oct 08 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 161.57 | 43 | 6,947 | 7,465 | 7.5 K to 7.5 K (-0.57 %) |
Oct 08 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 160.65 | 104 | 16,708 | 7,508 | 7.6 K to 7.5 K (-1.37 %) |
Oct 08 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 159.47 | 49 | 7,814 | 7,612 | 7.7 K to 7.6 K (-0.64 %) |
Oct 08 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 161.57 | 2,157 | 348,516 | 372,535 | 374.7 K to 372.5 K (-0.58 %) |
Oct 08 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 160.65 | 5,197 | 834,911 | 374,692 | 379.9 K to 374.7 K (-1.37 %) |
Oct 08 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 159.49 | 2,450 | 390,738 | 379,889 | 382.3 K to 379.9 K (-0.64 %) |
Sep 26 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 165.05 | 1,400 | 231,070 | 1,307,205 | 1.3 M to 1.3 M (-0.11 %) |
Sep 26 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 164.43 | 1,699 | 279,367 | 1,308,605 | 1.3 M to 1.3 M (-0.13 %) |
Sep 26 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 162.92 | 1,111 | 181,004 | 1,310,304 | 1.3 M to 1.3 M (-0.08 %) |
Sep 26 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 161.99 | 3,369 | 545,744 | 1,311,415 | 1.3 M to 1.3 M (-0.26 %) |
Sep 26 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 161.14 | 1,925 | 310,195 | 1,314,784 | 1.3 M to 1.3 M (-0.15 %) |
Sep 26 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 160.07 | 5,202 | 832,684 | 1,316,709 | 1.3 M to 1.3 M (-0.39 %) |
Sep 26 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 165.51 | 100 | 16,551 | 1,321,911 | 1.3 M to 1.3 M (-0.01 %) |
Sep 26 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 164.98 | 12,993 | 2,143,585 | 1,322,011 | 1.3 M to 1.3 M (-0.97 %) |
Sep 26 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 164.01 | 10,951 | 1,796,074 | 1,335,004 | 1.3 M to 1.3 M (-0.81 %) |
Sep 26 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 162.97 | 3,644 | 593,863 | 1,345,955 | 1.3 M to 1.3 M (-0.27 %) |
Sep 26 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 161.76 | 4,906 | 793,595 | 1,349,599 | 1.4 M to 1.3 M (-0.36 %) |
Sep 26 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 160.75 | 2,700 | 434,025 | 1,354,505 | 1.4 M to 1.4 M (-0.20 %) |
Sep 15 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 171.22 | 1,000 | 171,220 | 41,538 | 42.5 K to 41.5 K (-2.35 %) |
Sep 15 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 175.00 | 50,000 | 8,750,000 | 1,357,205 | 1.4 M to 1.4 M (-3.55 %) |
Sep 10 2014 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Sell | S | 170.32 | 5,000 | 851,600 | 574,023 | 579 K to 574 K (-0.86 %) |
Sep 15 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 27.46 | 3,000 | 82,380 | 5,007 | |
Sep 15 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 175.00 | 3,000 | 525,000 | 21,713 | 24.7 K to 21.7 K (-12.14 %) |
Sep 15 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 27.46 | 3,000 | 82,380 | 24,713 | 21.7 K to 24.7 K (+13.82 %) |
Sep 10 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 27.46 | 2,500 | 68,650 | 8,007 | |
Sep 10 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 170.00 | 2,500 | 425,000 | 21,713 | 24.2 K to 21.7 K (-10.33 %) |
Sep 10 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 27.46 | 2,500 | 68,650 | 24,213 | 21.7 K to 24.2 K (+11.51 %) |
Sep 10 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Option Exercise | M | 46.83 | 667 | 31,236 | 56,939 | |
Sep 10 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Sell | S | 168.00 | 1,852 | 311,136 | 50,619 | 52.5 K to 50.6 K (-3.53 %) |
Sep 10 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Buy | M | 46.83 | 667 | 31,236 | 52,471 | 51.8 K to 52.5 K (+1.29 %) |
Sep 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 163.88 | 38 | 6,227 | 7,661 | 7.7 K to 7.7 K (-0.49 %) |
Sep 04 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 162.71 | 159 | 25,871 | 7,699 | 7.9 K to 7.7 K (-2.02 %) |